The Lowdown on Post Transplant Cyclophosphamide
A recent study explored the use of post-transplant high-dose cyclophosphamide (PTCy) in haematopoietic cell transplantation (HCT) from mismatched unrelated donors (MMUD) in patients with acute myeloid malignancies. The research focused on whether PTCy, along with a calcineurine inhibitor and my